NCT03198767View on ClinicalTrials.gov

Effects of Carbohydrate in Diet and Supplements on the Gastrointestinal Tolerability of LIK066

PHASE2CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

June 21, 2017

Primary Completion Date

September 4, 2017

Study Completion Date

September 4, 2017

Conditions
Obesity
Interventions
DRUG

LIK066

LIK066 50 mg tablets. Open-label, bulk, blister-pack.

DIETARY_SUPPLEMENT

Carbohydrate 50%

50% carbohydrate in breakfast meal

DIETARY_SUPPLEMENT

Carbohydrate 25%

25% carbohydrate in breakfast meal

DIETARY_SUPPLEMENT

Carbohydrate 8%

8% carbohydrate in breakfast meal

DIETARY_SUPPLEMENT

Carbohydrate 0%

0% carbohydrate in breakfast meal

DIETARY_SUPPLEMENT

Psyllium

Powder 6 grams

DIETARY_SUPPLEMENT

Calcium carbonate

Liquid 1 gram (4 mL equivalent sugar free)

Trial Locations (1)

68502

Novartis Investigative Site, Lincoln

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY